Metabolism, pharmacokinetics and excretion of a potent tachykinin NK1 receptor antagonist (CP-122,721) in rat: Characterization of a novel oxidative pathway

By Kamel A.   Davis J.   Potchoiba M. J.   Prakash C.  

Xenobiotica, Vol. 36, Iss. 2-3, 2006-02 ,pp. : 235-258

Informa Healthcare

Access to resources Recommend Favorite

Central effects of selective NK 1 and NK 3 tachykinin receptor agonists on two models of experimentally-induced colitis in rats

By Improta G.   Carpino F.   Petrozza V.   Guglietta A.   Tabacco A.   Broccardo M.  

Peptides, Vol. 24, Iss. 6, 2003-06 ,pp. : 903-911

Elsevier

Access to resources Recommend Favorite

Metabolism and excretion of CP-122,721, a non-peptide antagonist of the neurokinin NK1 receptor, in dogs: Identification of the novel cleaved product 5-trifluoromethoxy salicylic acid in plasma

By Kamel A.   Du Y.   Colizza K.   Prakash C.  

Xenobiotica, Vol. 37, Iss. 5, 2007-05 ,pp. : 559-578

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-5: a novel target for asthma therapy

By Blümchen K.   Kallinich T.   Hamelmann E.  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 3, 2001-05 ,pp. : 433-453

Informa Healthcare

Access to resources Recommend Favorite

Crystal Structure of an Enzyme Displaying both Inositol-polyphosphate-1-Phosphatase and 3′-Phosphoadenosine-5′-phosphate Phosphatase Activities: A Novel Target of Lithium Therapy

By Patel S.   Yenush L.   Rodríguez P.L.   Serrano R.   Blundell T.L.  

Journal of Molecular Biology, Vol. 315, Iss. 4, 2002-01 ,pp. : 677-685

Academic Press

Access to resources Recommend Favorite